BGXX

Bright Green Corporation (BGXX) | Rumor.io

Bright Green

BGXX

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-13.1M

Social

What share of all stock conversation is about BGXX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Sep 19

Bright Green Corporation (BGXX) has been temporarily delisted from the Nasdaq due to non-compliance with rules.
The company is working to relist on the Nasdaq through an acquisition or by meeting the compliance requirements, and has filed a proxy vote for shareholders to consider a reverse stock split.
Despite the delisting, the company's plans and growth prospects remain unchanged, and it will continue to trade on the OTC market, which is common for US cannabis companies.

Generated by AI

Sentiment

Of the messages about BGXX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100%	81.91% +2.6
Bearish	—	—	0%	18.09% -2.6

Bullish· Jun 6

$BGXX has the potential to 10x in value from its current price, with impressive DD that is "legit mind blowing" and a strong chance of being a "home run".
The company's treatment of influenza and its production of Tetrahydrocannabinol, a drug designed to combat the disease, is making it a top play in the bird flu/influenza theme and has the potential to make investors rich.
$BGXX is expected to break through the $1 price level, with a target projection of $1.04, and has a strong chance of reaching this target quickly once it crosses the 50 EMA at $0.4444.

Bearish· Jun 6

The company's stock price has dropped significantly, with some users mentioning a drop from +10% to -11%.
The stock has experienced a large short sale spike, with 4 million shares shorted in one day.
The company's stock price may be vulnerable to a "next Pfizer" scenario, where the stock price is artificially inflated due to speculative trading and subsequent collapse.

Generated by AI

Topics

Of the messages about BGXX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Mar 12

Bright Green Corporation (BGXX) is expanding its controlled substances drug production facility in Grants, New Mexico by $250 million and has secured $60 million in financing.
The expansion is part of the company's "Drugs Made In America" plan, aiming to mitigate national security risks associated with dependency on foreign imports.
CEO Groovy Singh expressed optimism about the impact of the expansion, highlighting Bright Green as the first company in almost a century to receive approval to produce controlled substances in the U.S.

Generated by AI

Community

Of the messages about BGXX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	91.89%
Newcomers	—	—	0%	8.11%

Regulars· Mar 12

$BGXX is up 55% on news of a major construction project that will add 7 million square feet of manufacturing and production capabilities to its facility in Grants, N.M.
The project will be carried out by Dalsem Greenhouse Technologies BV, a contractor with expertise in greenhouse and production facility design.
The expansion is expected to significantly increase Bright Green Corporation's production capabilities, potentially leading to increased revenue and stock value.

Newcomers· Jun 6

The newcomer is focused on Bright Green Corporation's (BGXX) potential for a 10x increase in value, citing "mind blowing" due diligence and a "home run" scenario.
The newcomer is concerned with adding to their BGXX position, planning to buy more on dips, and seeing the stock as a top play in the bird flu/influenza theme.
The newcomer believes that BGXX's Tetrahydrocannabinol drug will drive the stock's price, with the company's current level comparable to another stock's massive move.

Generated by AI

Also Discussed

Investors talking about BGXX also mention

#	Name	Attention
1	MGAM - Mobile Global Esports Inc.	——
2	LFLY - Leafly Holdings, Inc.	——
3	MHUA - Meihua International Medical Technologies Co., Ltd.	——
4	Grove Collaborative Holdings, Inc.GROV	0%new
5	Comera Life Sciences Holdings Inc.CMRA	0%0
6	AMTD Digital Inc. ADRHKD	0%new
7	VEDU - Visionary Holdings Inc.	——
8	Swvl Holdings Corp Class A Common SharesSWVL	0%0
9	HPCO - Hempacco Co., Inc.	——
10	JE Cleantech Holdings Ltd.JCSE	0%0

Bright Green Corporation

Healthcare
Drug Manufacturers - Specialty & Generic

Bright Green Corporation is a producer and exporter of legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States. Its products support research, manufacturing, export activities, and the production of medical cannabis products and preparations. The company holds DEA authorization for cultivating and manufacturing Schedule I and II plant-based controlled substances, positioning it as a domestic supplier of raw materials for cannabinoid, psychedelic, and opioid-based drugs used in pharmaceutical applications. Incorporated in 2019 and headquartered in Grants, New Mexico, Bright Green Corporation operates a facility designed for compliance with federal and state regulations for controlled substance production. It focuses on plant-based active pharmaceutical ingredients (APIs) and has pursued partnerships to supply DEA-approved extracts for cGMP pharmaceutical-grade production. Currently under Chapter 11 reorganization filed in February 2025, the company maintains its core operations in the healthcare sector, specifically drug manufacturing for specialty and generic medicinal chemicals and botanical products.

Website

Location

1033 George Hanosh Boulevard

Grants, NM, 87020

United States

Social

What share of all stock conversation is about BGXX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Sep 19

Bright Green Corporation (BGXX) has been temporarily delisted from the Nasdaq due to non-compliance with rules.
The company is working to relist on the Nasdaq through an acquisition or by meeting the compliance requirements, and has filed a proxy vote for shareholders to consider a reverse stock split.
Despite the delisting, the company's plans and growth prospects remain unchanged, and it will continue to trade on the OTC market, which is common for US cannabis companies.

Generated by AI

Sentiment

Of the messages about BGXX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100%	81.91% +2.6
Bearish	—	—	0%	18.09% -2.6

Bullish· Jun 6

$BGXX has the potential to 10x in value from its current price, with impressive DD that is "legit mind blowing" and a strong chance of being a "home run".
The company's treatment of influenza and its production of Tetrahydrocannabinol, a drug designed to combat the disease, is making it a top play in the bird flu/influenza theme and has the potential to make investors rich.
$BGXX is expected to break through the $1 price level, with a target projection of $1.04, and has a strong chance of reaching this target quickly once it crosses the 50 EMA at $0.4444.

Bearish· Jun 6

The company's stock price has dropped significantly, with some users mentioning a drop from +10% to -11%.
The stock has experienced a large short sale spike, with 4 million shares shorted in one day.
The company's stock price may be vulnerable to a "next Pfizer" scenario, where the stock price is artificially inflated due to speculative trading and subsequent collapse.

Generated by AI

Topics

Of the messages about BGXX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Mar 12

Bright Green Corporation (BGXX) is expanding its controlled substances drug production facility in Grants, New Mexico by $250 million and has secured $60 million in financing.
The expansion is part of the company's "Drugs Made In America" plan, aiming to mitigate national security risks associated with dependency on foreign imports.
CEO Groovy Singh expressed optimism about the impact of the expansion, highlighting Bright Green as the first company in almost a century to receive approval to produce controlled substances in the U.S.

Generated by AI

Community

Of the messages about BGXX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	91.89%
Newcomers	—	—	0%	8.11%

Regulars· Mar 12

$BGXX is up 55% on news of a major construction project that will add 7 million square feet of manufacturing and production capabilities to its facility in Grants, N.M.
The project will be carried out by Dalsem Greenhouse Technologies BV, a contractor with expertise in greenhouse and production facility design.
The expansion is expected to significantly increase Bright Green Corporation's production capabilities, potentially leading to increased revenue and stock value.

Newcomers· Jun 6

The newcomer is focused on Bright Green Corporation's (BGXX) potential for a 10x increase in value, citing "mind blowing" due diligence and a "home run" scenario.
The newcomer is concerned with adding to their BGXX position, planning to buy more on dips, and seeing the stock as a top play in the bird flu/influenza theme.
The newcomer believes that BGXX's Tetrahydrocannabinol drug will drive the stock's price, with the company's current level comparable to another stock's massive move.

Generated by AI

Bright Green

Social

Sep 19

Sentiment

Bullish· Jun 6

Bearish· Jun 6

Topics

Mar 12

Community

Regulars· Mar 12

Newcomers· Jun 6

Also Discussed

Bright Green Corporation

Company Information

Location

Also Discussed

Social

Sep 19

Sentiment

Bullish· Jun 6

Bearish· Jun 6

Topics

Mar 12

Community

Regulars· Mar 12

Newcomers· Jun 6